Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference
SEATTLE, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the Cowen 45th Annual Health Care Conference at 3:10 p.m. ET on Monday, March 3, 2025. The presentation will feature a business overview and update by Steve Harr, Sana's President and Chief Executive Officer.
The webcast will be accessible on the Investor Relations page of Sana's website at https://sana.com/. A replay of the presentation will be available at the same location for 30 days following the conference.
About Sana BiotechnologySana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are a passionate group of people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, WA, Cambridge, MA, South San Francisco, CA, and Bothell, WA. For more information about Sana Biotechnology, please visit https://sana.com/.
Cautionary Note Regarding Forward-Looking StatementsThis press release contains forward-looking statements about Sana Biotechnology, Inc. (the 'Company,' 'we,' 'us,' or 'our') within the meaning of the federal securities laws, including those related to the Company's vision; the Company's participation at the Cowen 45th Annual Health Care Conference; and the subject matter of the Company's presentation at the conference. All statements other than statements of historical facts contained in this press release, including, among others, statements regarding the Company's strategy, expectations, cash runway and future financial condition, future operations, and prospects, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as 'aim,' 'anticipate,' 'assume,' 'believe,' 'contemplate,' 'continue,' 'could,' 'design,' 'due,' 'estimate,' 'expect,' 'goal,' 'intend,' 'may,' 'objective,' 'plan,' 'positioned,' 'potential,' 'predict,' 'seek,' 'should,' 'target,' 'will,' 'would' and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. The Company has based these forward-looking statements largely on its current expectations, estimates, forecasts and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. These statements are subject to risks and uncertainties that could cause the actual results to vary materially, including, among others, the risks inherent in drug development such as those associated with the initiation, cost, timing, progress and results of the Company's current and future research and development programs, preclinical and clinical trials, as well as economic, market and social disruptions. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in the Company's SEC reports, including but not limited to its Annual Report on Form 10-Q dated November 8, 2024. Except as required by law, the Company undertakes no obligation to update publicly any forward-looking statements for any reason.
Investor Relations & Media:Nicole Keithinvestor.relations@sana.commedia@sana.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
More Americans turning to weight loss drugs to shed weight
HARTFORD, Conn. (WTNH) — More Americans are turning to medical weight loss drugs to lose weight. Before you start, you may want to think about speaking with a registered dietitian nutritionist. Hartford HealthCare's Cody Krawec, a clinical nutrition manager at St. Vincent's Medical Center, joined Good Morning Connecticut at 9 a.m. to explain. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
33 minutes ago
- Yahoo
Stock Market Today: Market rises on China talks
Stock Market Today: Market rises on China talks originally appeared on TheStreet. Updated: 11:41 a.m. ET. Stocks reversed early losses after President Donald Trump and Chinese President Xi Jinping spoke for more than 90 minutes Thursday morning and agreed to a high-level meeting on trade disputes in the near future. The Standard & Poor's 500 Index was up 0.4% to 5,995. The Nasdaq Composite Index had risen 0.7% to 19,592. The Dow Jones Industrial Average was sporting a 0.3% gain to 42,561. The call also touched on Chinese reluctance to approve export licenses on rare earth minerals, critical components used in the manufacture of electric vehicles. No resolution was announced, however. Auto makers have been struggling to obtain enough of materials to make high-end magnets and have feared having to shut down assembly lines with the materials, especially dysprosium and terbium. Trump said the call came to "a positive conclusion." A week ago, the administration had charged China with stalling on trade talks. Trump named Treasury Secretary Scott Bessent, Commerce Secretary Howard Ludnick and Trade Representative Jamieson Greer to meet with Chinese counterparts to try to resolve problems. No date was set. Tesla () shares were down 3.2% to $321.11; they had been down as much as5%. Costco Wholesale () slipped 2.6% to $1,025 on signs sales growth was easing. Crude oil was higher to $63.44. Gold was off slightly. The 10-year Treasury yield had moved up to 4.395%. Updated: 10:06 a.m. The Standard & Poor's 500 Index was off 0.2% to 5,958. The Nasdaq Composite Index was off 0.1% to 19436. The Dow Jones Industrial Average was off 0.4%, or 159 points, to 42,283. Tesla shares were off, possibly in reaction to CEO Elon Musk's criticisms of the new tax bill. The market had little reaction to a report that President Donald Trump had had a phone call with Chinese Xi Jinping. The Chinese government reported the call, and few details were available. Futures trading suggested stocks will open modestly higher. The Standard & Poor's 500 Index was looking at a 14-point gain. The Nasdaq-100 Index was signaling a 48-point jump. The Dow Jones Industrial Average was surging to a possible 100-point jump at the open. Meanwhile, the U.S. trade deficit shrank to $61.6 billion in April, an steeper move than Wall Street had forecast. It had ballooned to a record in March as businesses rushed to stockpile ahead of President Donald Trump's tariff initial jobless claims unexpectedly rose last week to the the highest since October, adding to signs that the job market is cooling. Initial claims increased 8,000 to 247,000 in the week ended May 31, a period that included Memorial Day. Continuing claims, a proxy for the number of people receiving benefits, fell slightly to 1.9 million in the previous week. But Bloomberg News noted the number remains elevated. Both suggest a weakening jobs market ahead of Fridays monthly unemployment report. Happy Thursday. We're doing something a little different today. We're kicking off the Stock Market Today column with comments from Stephen 'Sarge' Guilfoyle's daily Market Recon. This is the type of great analysis he provides every day over in TheStreet Pro. It could have gotten ugly, one might have thought. The information started trickling out on Wednesday morning. It certainly wasn't pretty. There was no bouquet of flowers tossed down from on high to brighten the mood. There would be no aroma of freshly baked bread wafting across the street to disguise the wretched stench of decay. There would be no knight in shining armor that could arise from the shadows to defend the citizenry from their fears. Still, as the numbers hit publication... as viewpoints expressing pessimism spread ... equity markets hung in there, supported by demand for debt securities that suppressed yields. That suppressed interest rates. So, it was. So now, it has been written. Suddenly, after a spate of negative reports had taken stocks down from their early morning and mid-morning highs, bond traders started buying U.S. Treasuries. On Wednesday, the U.S. 10-Year note, our nation's benchmark debt security, went out paying just 4.36%, down 11 basis points for the day. The 2-Year Note yielded just 3.88% (-8 bps) by day's end. The prospect for lower interest rates going forward allowed stocks to breathe and hold their levels on a day that they might otherwise have suffered a bout of profit taking. Just a day after investors had seen the S&P 500 technically confirm last Thursday's bullish change of trend. Friday's Bureau of Labor Statistics Employment Report for May could still turn markets on their ear, Or not. The "big, beautiful bill" could pass. Or not. Talks between Pres. Trump and China's Pres. Xi could go well. Or not. Heads on a swivel, gang. Two sources of water. Clean socks. Full battle rattle. What impacted the markets on Wednesday? What's about to impact our marketplace? Let's go... Uh oh. On Wednesday morning, the ADP Report on private sector hiring for May showed just 37,000 jobs created during the month. This was the fewest jobs shown as having been created by this report for any single month in more than two years. This shows a deceleration from April's creation of 60,000 private sector jobs and badly missed the consensus view for 110,000 jobs created. This does not necessarily mean that Friday's Bureau of Labor Statistics print will be weak, but it could. Anything this ugly on Friday will not pass unnoticed by investors. The ISM Non-Manufacturing Index hit the tape at 49.9 (50 is the line in these surveys between expansion and contraction), just a few days after the ISM Manufacturing Index had crossed the tape at 48.5. The real worry for May is the component labeled "New Orders," which is the single most important item in any business survey. For the month New Orders printed at 46.4 for Services and 47.6 for Manufacturing. That's nasty. Inventories and Backlogged Orders both also showed decay. Didn't anything show expansion? Oh, you bet your tail something did. Inflation did. Prices printed at a red hot 68.7 for the services economy and a white hot 69.4 for the manufacturing economy. Does that mean that we'll see reacceleration of consumer level inflation for May? I would think this is likely. We'll almost certainly see that producer level inflation has come back to life. The Federal Reserve released their Beige Book on Wednesday afternoon. The Beige Book, for the new kids, is a central bank publication containing anecdotal economic information from across the Fed's 12 regional districts, released eight times a year ahead of policy decisions. The Fed will make its next decision on monetary policy on June 18. On overall economic activity: "Reports across the 12 Federal Reserve Districts indicate that economic activity has declined slightly since the previous report. Half of the Districts reported slight to moderate declines in activity, three Districts reported no change, and three Districts reported slight growth." Boston... "Economic activity decreased slightly overall." New York... "Economic activity in the Second District continued to decline modestly amid heightened uncertainty." Philadelphia... "Business activity declined modestly in the current Beige Book period, as it did in the last period." Minneapolis... "The District contracted slightly overall." Kansas City... "Overall activity declined moderately, driven by lower retail spending, a decline in the demand for single-family homes, and a slight contraction in manufacturing." San Francisco... "Economic activity slowed slightly." Elsewhere, Richmond, Atlanta and Chicago reported slight expansion, while Dallas, Cleveland and St. Louis reported no change in business activity. Fed Funds Futures markets trading in Chicago are now pricing in a 76% probability for a quarter-point rate cut on Sept. 17 and a 54% likelihood for another quarter-point rate cut on Oct. 29. That would be it for the year. Two more rate quarter-percentage point cuts are currently being priced in for 2026. The Congressional Budget Office, which is non-partisan, but not always correct, assessed the president's "big, beautiful bill" and reported on Wednesday its expectation that over 10 years the bill, if passed into law, would increase deficits by $2.4 trillion. There is a real concern over passage in the Senate now, with a number of fiscal conservatives fretting that the budget cuts in the bill don't go far enough and other senators showing dismay that these cuts go too far. I tend to agree with the fiscal hawks here, as that is my nature as an economist. That, my friends, is neither here nor there. What matters is that the U.S. Dollar Index traded lower on this news and that while Treasury securities showed strength due to weakness in the above economic news, that the long end of the spectrum of Treasury securities could become unanchored should the federal government continue to behave in a fiscally reckless manner. The weaker dollar would indeed be inflationary. On Wednesday, the S&P 500 closed essentially flat (+0.01%), while the Nasdaq Composite gained 0.32% thanks to a 1.39% run made by the Philadelphia Semiconductor Index. Marvell Technologies () and ON Semiconductor () led that group for the day. Otherwise, not a lot changed on Wednesday. The Dow Transports gave up 0.46%, while the small to midcap indices all gave back between 0.2% and 0.26%. Six of the 11 S&P sector SPDR ETFs closed out Wednesday's regular session in the green, led by the Communication Services () fund that only gained 0.64%. While only five of these funds closed in the red, Energy () gave up 1.95% as exploration, refining and pipeline stocks all took a pounding, and the Utilities () gave back 1.75%. Winners beat losers on the NYSE on Wednesday by just three issues. This was largely a 50/50 split. Winners did lead losers at the Nasdaq by a 6-to-5 margin. Advancing volume did take a nifty 65.5% share of composite Nasdaq-listed trade on Wednesday, but just a 45.8% share of composite NYSE-listed activity. Most importantly, on a day-over-day basis, aggregate trade contracted across NYSE-listings by 5.2% and across Nasdaq-listed securities by 3.7%. Aggregate trade across the membership of the S&P 500 also fell 9% short of the trading volume 50-day simple moving average for the index on Wednesday after falling just 4% short of that line in the sand on Tuesday. Does this render Wednesday's market as less significant that it might otherwise be? In short, technically, the answer is "yes." Price discovery is always more meaningful and more impactful when increased trading volume implies increased professional participation. Readers will see just how incredibly accurate technical analysis has been through this recent period. On Wednesday, the index, though quiet, did build on Tuesday's confirmation of Thursday's change in trend. Is Advanced Micro Devices () getting ready to make a serious run at industry leader Nvidia () ? Is Lisa Su getting ready to make a serious run at Jensen Huang? Maybe. Check out these past few moves that largely flew under the radar: June 4th: AMD announces the acquisition of open-source software company Brium in an effort to further its prowess in generative artificial intelligence. Terms of the deal were not disclosed. May 28th: AMD announced the acquisition of silicon photonics company Enosemi to boost co-packaging and the firm's prowess in generative AI. Terms of the deal were not disclosed. May 20th: AMD announced the divestiture of its ZT Systems, which is a data center manufacturing company for $3 billion. But the firm retained ZT's 1,200-person engineering team at a cost of about $1.6 billion or $1.33 million per engineer. This should improve AMD's competitiveness in the data center GPU market. My Conclusion? AMD is back among my top 10 holdings when ranked by weighting (number 10) after a long hiatus. We skipped much of the 2024 decline. Our net basis is currently $99.91. I expect to continue to buy the stock on weakness when that opportunity arises going forward. Nvidia remains my 15th heaviest allocation. I have no plans to add. 08:30 - Initial Jobless Claims (Weekly): Expecting 230K, Last 229K. 08:30 - Continuing Claims (Weekly): Last 1.919M. 08:30 - Balance of Trade (Apr): Last $-140.5B. 08:30 - Non-Farm Productivity (Q1-F): Flashed -0.8% q/q. 08:30 - Unit Labor Costs (Q1-F): Flashed 5.7% q/q. 10:30 - Natural Gas Inventories (Weekly): Last +101B cf. 12:00 p.m. - Speaker: Reserve Board Gov. Adriana Kugler. 1:30 - Speaker: Philadelphia Fed Pres. Patrick Harker. Before the Open: () (.52) After the Close: () (1.57), () (.81), () (2.60) At the time of publication, Guilfoyle was long AMD, NVDA equity. Stock Market Today: Market rises on China talks first appeared on TheStreet on Jun 5, 2025 This story was originally reported by TheStreet on Jun 5, 2025, where it first appeared.
Business Wire
35 minutes ago
- Business Wire
Johnson Fistel Investigates Quantum Computing: Long-Term Investors Encouraged to Reach Out
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Quantum Computing Inc. (NASDAQ: QUBT) ('QCI' or 'the Company') in relation to their obligations to the company's shareholders. Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Quantum Computing Inc. (NASDAQ: QUBT) ('QCI' or 'the Company') in relation to their obligations Share What can I do? If you are a current long-term QCI shareholder, you may have legal claims that may be brought on behalf of the company, against the company's directors and officers. If you wish to discuss this notice or your legal rights, please contact lead analyst Jim Baker (jimb@ at 619-814-4471. If emailing, please include a phone number. If you have continuously owned QCI shares, you can click or copy and paste the link below in a browser to join: What is this about? Recently a class action complaint was filed against QCI alleging that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose: (1) Defendants overstated the capabilities of QCI's quantum computing technologies, products, and/or services; (2) Defendants overstated the scope and nature of QCI's relationship with NASA, as well as the scope and nature of QCI's NASA-related contracts and/or subcontracts; (3) Defendants overstated QCI's progress in developing a TFLN foundry, the scale of the purported TFLN foundry, and orders for the Company's TFLN chips; (4) QCI's business dealings with Quad M Solutions, Inc. and millionways, Inc. both qualified as related party transactions; (5) accordingly, QCI's revenues relied, at least in part, on undisclosed related party transactions; (6) all the foregoing, once revealed, was likely to have a significant negative impact on QCI's business and reputation; and (7) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times. About Johnson Fistel, PLLP: Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Colorado, and Idaho. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit Attorney advertising. Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
